Bacteremic pneumonia due to gram-negative bacilli.

Area of Science:

• Infectious Diseases
• Critical Care Medicine
• Bacteriology

Background:

• Aerobic gram-negative bacilli are significant pathogens in hospital-acquired infections.
• Bacteremic pneumonia presents a severe clinical challenge, particularly in vulnerable patient populations.
• Previous studies highlight the difficulty in treating gram-negative bacterial infections.

Purpose of the Study:

• To investigate the clinical characteristics and outcomes of bacteremic pneumonia caused by aerobic gram-negative bacilli.
• To assess the mortality rate and contributing factors in elderly patients with this severe infection.
• To evaluate the effectiveness of amikacin sulfate therapy in managing these infections.

Main Methods:

• Retrospective analysis of 27 patients diagnosed with aerobic gram-negative bacilli bacteremic pneumonia over a 20-month period.
• Data collection included patient demographics, underlying conditions, causative organisms, treatment regimens, and mortality.
• Antimicrobial susceptibility testing was performed for all isolates.

Main Results:

• A high mortality rate of 81.5% was observed in elderly patients (mean age 61.2 years) with serious underlying diseases.
• Bacteremic pneumonia represented 14.1% of all gram-negative bacteremia cases but accounted for 39.4% of total deaths.
• Treatment with amikacin sulfate, guided by susceptibility testing, did not significantly reduce mortality.

Conclusions:

• Bacteremic pneumonia due to aerobic gram-negative bacilli carries a poor prognosis, especially in elderly patients with comorbidities.
• The high mortality associated with this condition appears independent of the specific infecting organism or patient's underlying disease.
• Further research is needed to identify more effective therapeutic strategies for this life-threatening infection.